Skip to content
‹ Back to IndustriesHealthcare

Learning the Language of Microbiological Control

Key Terms for Water Treatment Novices Water treatment specialists can forget that their clients may not understand the technical terms used in our industry. The language of microbiological control can be particularly confusing. To help establish a common working vocabulary, it’s important to define some key terms. Let’s get started! Types of Microorganisms Microorganisms are living…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

Key Terms for Water Treatment Novices

Water treatment specialists can forget that their clients may not understand the technical terms used in our industry. The language of microbiological control can be particularly confusing. To help establish a common working vocabulary, it’s important to define some key terms. Let’s get started!

Types of Microorganisms

Microorganisms are living organisms that require high magnification to see because they are so small.

Bacteria are single cell microorganisms that require water, but not light, for normal grow. They are so small (0.5 to 5.0 micron) that it would take 200,000 to two million bacteria placed end to end to measure a yard. Under ideal conditions, bacteria populations can double every 15 minutes. There are over 10,000 distinct species of bacteria, many of which can cause serious problems in water systems.

Aerobic bacteria require oxygen for growth. Many types of aerobic bacteria can form thick, sticky biofouling deposits that can block water flow, reduce heat transfer, increase pumping costs, cause corrosion, and increase the potential for disease. These deposits are generically called slime, and result from bacteria forming protective biofilms on system surfaces.

Anaerobic bacteria require an absence of oxygen for growth. They can often be found growing underneath biofilms and biofouling deposits. Anaerobic bacteria including Sulfate Reducing Bacteria (SRB) are a major cause of microbiologically influenced corrosion (MIC) in water systems. Many anaerobic bacteria produce spores as a survival mechanism and can be cultivated from oxygenated water.

Protozoa are single cell microorganisms that can move independently, and feed on biofilm associated bacteria and waste products. Amoebae are a type of protozoa. Although microscopic, protozoa are typically 5 to 100 times larger than bacteria. The presence of protozoa in a water system indicates advanced microbiological growth associated with biofilms.

Legionella is a common waterborne bacteria that can cause a serious, sometimes fatal illness called Legionnaires’ disease in exposed individuals. It is caused by inhaling aerosolized droplets of water containing an infectious amount of Legionella bacteria. It is characterized by fever, chills, lung congestion, and severe pneumonia. The elderly, sick, immunocompromised, and smokers are most susceptible to develop Legionnaires disease upon exposure. Over 50 different species of Legionella have been identified. Only about half of the species have been associated with disease,

Colonization Characteristics

Microorganisms can be classified based on their colonization characteristics:

Planktonic bacteria are “free floating” in the bulk system water. Whether performed in a laboratory or in the field using dip slides, bacteria culture tests on water samples only measure planktonic bacteria counts.

Sessile bacteria are “surface attached” associated with biofilm deposits. Sessile bacteria are not detected by bulk water bacteria counts.

Biofilms are complex communities of surface attached bacteria growing inside a protective microbial secretion often called slime. Although biofilms start out microscopic in size, they can grow into visible biofouling deposits in just a matter of days. A wide range of problem causing microorganisms can grow to high levels protected within biofilms and associated microorganisms, especially amoebae. Once established, biofilms are difficult to remove and kill.

Extracellular Polymeric Substances (EPS) are microbial secretions that establish the foundation for biofilms and biofouling deposits. EPS secretions tightly bind biofilms to systems surfaces and protect growing microorganisms from environmental hazards including high level cleaner and biocide additions.

Biocides Types

Oxidizing biocides kill or inhibit bacteria growth by physically destroying cell structures. Chemical compounds that fall into this category are chlorine, bromine and peroxide.

Non-oxidizing biocides kill bacteria by interfering with essential metabolic processes, in effect poisoning the bacteria. Some common non-oxidizing biocides are glutaraldehyde and isothiazolin.

Sanitize, Disinfect, or Sterilize?

Although the exact definition will vary depending on the application, these terms refer to the relative effectiveness of processes for eradicating harmful microorganisms. The lowest level of cleaning and microbial control is sanitizing, following by disinfection, and then sterilization.

  • Sanitizing involves physical and chemical cleaning processes that reduce the number of microorganisms.
  • Disinfection involves adding disinfection chemicals in low-level, intermediate level or high-level control strategies.
  • Sterilization involves using chemicals, temperature, gas and/or pressure to kill or inactivate all disease-causing bacteria, spores, fungi and viruses

The First Step in Problem Solving

Understanding the terms used in the water treatment industry is always the first step in proper problem solving. Everyone working together on a problem must have the same basic knowledge of terms used in describing the conditions and the appropriate corrective tools. We will then be in a better position to achieve our common goal of maintaining clean cooling water systems that are free from uncontrolled microbiological growth.

Chem-Aqua provides custom water treatment solutions. We specialize in providing custom designed water treatment programs for boiler, cooling, and process water systems. We help our customers minimize their energy, water, and maintenance costs while ensuring safe and reliable operation of these critical systems.

Read more at chemaqua.com

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Up to 0.864 in U.S. and Austrian ICUs, 0.698 in China

Up to 0.864 in U.S. and Austrian ICUs, 0.698 in China

ELDER-ICU, an ICU mortality prediction model for patients 65+, reached up to 0.864 AUROC in U.S. and Austrian cohorts but 0.698 at a site in China. The results highlight that performance can vary across settings, so hospitals buying AI built elsewhere should validate it on local patients and ensure contracts allow recalibration or retraining when needed.

  • 01A vendor's validation claim is only as good as the patients it was tested on: one ICU mortality model scored 0.804 to 0.864 AUROC in U.S. and Austrian hospitals and 0.698 in China.
  • 02Match the fix to the failure. Recalibration improved probability accuracy at every site, while only retraining on local data recovered the bigger ranking losses at the South Korean and Chinese sites (+0.066 and +0.076 AUROC).
  • 03Checking AI on local patients takes staff and contract terms: whether the license permits local recalibration or retraining, and who on the team can run it.

Nov 17, 2026

Epic's seven bets beyond the EHR, sorted by when hospitals can actually use them

Epic's seven bets beyond the EHR, sorted by when hospitals can actually use them

Epic is expanding past its EHR into ERP, IT staffing, AI, drug pricing and payer technology. Delivery runs from tools live today to a full EpicOps rollout that may not arrive until 2029. The payer platform has the clearest proof point: St. Luke's and UnitedHealthcare automated status updates on 88% of the claims they exchanged.

  • 01Epic's payer platform is the expansion bet with a measured result: 88% of claim status updates automated between St. Luke's and UnitedHealthcare, plus a 25% drop in status calls.
  • 02EpicOps, Epic's ERP suite, may not be fully available until 2029, so a health system whose ERP commitments end sooner can test individual modules alongside its current system without a full switch.
  • 03Before using any integration with Epic's ambient AI, verify in your environment that the necessary write operations are supported, as FHIR support doesn't ensure full access.

Nov 16, 2026

Avanlee Care’s $3.5M seed tests whether Medicare Advantage plans will pay to reach caregivers

Avanlee Care’s $3.5M seed tests whether Medicare Advantage plans will pay to reach caregivers

Avanlee Care raised a $3.5 million seed round led by BEA Venture Fund, bringing total funding to $6 million. The startup helps Medicare Advantage plans find and support members' family caregivers. Its bet: plans will pay to reach whoever books the visits.

  • 01Medicare Advantage plans can see overdue visits and refills; Avanlee Care’s $3.5M seed backs a per-member-per-month model to reach the family caregiver who can act on that outreach.
  • 02Caregiver support among Medicare Advantage Special Needs Plans rose from 5% of plans in 2025 to 16% in 2026, even as meals and transportation benefits declined. That gives benefit designers a reference point.

Nov 15, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512